{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:33:22Z","timestamp":1788050002320,"version":"build-2784847793"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:sec id=\"ab-psc240001-1\"><jats:title>Importance<\/jats:title><jats:p>There is a recognized unmet need for clinical trials to provide evidence-informed care for infants, children and adolescents. This Special Communication outlines the capacity of 3 distinct trial design strategies, sequential, parallel, and a unified adult-pediatric bayesian adaptive design, to incorporate children into clinical trials and transform this current state of evidence inequity. A unified adult-pediatric whole-of-life clinical trial is demonstrated through the <jats:italic>Staphylococcus aureus<\/jats:italic> Network Adaptive Platform (SNAP) trial.<\/jats:p><\/jats:sec><jats:sec id=\"ab-psc240001-2\"><jats:title>Observations<\/jats:title><jats:p>Bayesian methods provide a framework for synthesizing data in the form of a probability model that can be used in the design and analysis of a clinical trial. Three trial design strategies are compared: (1) a sequential adult-pediatric bayesian approach that involves a separate, deferred pediatric trial that incorporates existing adult trial data into the analysis model to potentially reduce the pediatric trial sample size; (2) a parallel adult-pediatric bayesian trial whereby separate pediatric enrollment occurs in a parallel trial, running alongside an adult randomized clinical trial; and (3) a unified adult-pediatric bayesian adaptive design that supports the enrollment of both children and adults simultaneously in a whole-of-life bayesian adaptive randomized clinical trial. The SNAP trial whole-of-life design uses a bayesian hierarchical model that allows information sharing (also known as borrowing) between trial age groups by linking intervention effects of children and adults, thereby improving inference in both groups.<\/jats:p><\/jats:sec><jats:sec id=\"ab-psc240001-3\"><jats:title>Conclusion and Relevance<\/jats:title><jats:p>Bayesian hierarchical models may provide more precision for estimates of safety and efficacy of treatments in trials with heterogenous populations compared to traditional methods of analysis. They facilitate the inclusion of children in clinical trials and a shift from children deemed therapeutic orphans to the vision of no child left behind in clinical trials to ensure evidence for clinical practice exists across the life course. The SNAP trial provides an example of a bayesian adaptive whole-of-life inclusion design that enhances trial population inclusivity and diversity overall, as well as generalizability and translation of findings into clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapediatrics.2024.2697","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:02:12Z","timestamp":1724079732000},"page":"1066","source":"Crossref","is-referenced-by-count":10,"title":["Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical Trials"],"prefix":"10.1001","volume":"178","author":[{"given":"Anita J.","family":"Campbell","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Perth, Western Australia, Australia"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthi","family":"Anpalagan","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Best","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand"},{"name":"The National Immunisation Advisory Centre, The University of Auckland, Auckland, New Zealand"},{"name":"Department of Infectious Diseases, Starship Children\u2019s Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Britton","sequence":"additional","affiliation":[{"name":"Sydney Medical School and Sydney Infectious Diseases, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Infectious Diseases and Microbiology, the Children\u2019s Hospital at Westmead, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"},{"name":"Antimicrobials Group, Murdoch Children\u2019s Research Institute, Melbourne, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hatcher","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Great Ormond Street Hospital for Children, London, United Kingdom"},{"name":"Infection, Immunity, and Inflammation Research Department, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett J.","family":"Manley","sequence":"additional","affiliation":[{"name":"The Royal Women\u2019s Hospital, Melbourne, Victoria, Australia"},{"name":"The Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Marsh","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"Centre for Child Health research, School of Medicine, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Webb","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand"},{"name":"Department of Infectious Diseases, Starship Children\u2019s Hospital, Auckland, New Zealand"},{"name":"Department of Paediatrics, Kidz First Children\u2019s \u2018Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Davis","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Charles Darwin Hospital, Darwin, Northern Territory, Australia"},{"name":"John Hunter Hospital, University of Newcastle, Newcastle, New South Wales, Australia"},{"name":"School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Mahar","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics, Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Centre for Epidemiology and Biostatistics Unit, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Centre for Data Science, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"McGlothlin","sequence":"additional","affiliation":[{"name":"Berry Consultants, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"McMullan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sydney Children\u2019s Hospital, Randwick, Sydney, New South Wales, Australia"},{"name":"School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meyer","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Kidz First Middlemore Hospital Auckland, Auckland, New Zealand"},{"name":"Department of Paediatrics: Child and Youth Health University of Auckland, Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Nourse","sequence":"additional","affiliation":[{"name":"Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Papenburg","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Division of Microbiology, Department of Clinical Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, St Joseph\u2019s Health Centre - Unity Health Toronto, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Scheuerman","sequence":"additional","affiliation":[{"name":"Pediatrics B and Pediatric Infectious Diseases Unit, Schneider Children Medical Center Israel, Petach Tikva, Israel"},{"name":"Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Snelling","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Strunk","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Neonatal Directorate Child and Adolescent Health Service, King Edward Memorial Hospital for Women, Subiaco, Western Australia, Australia"},{"name":"Telethon Kids Institute, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stark","sequence":"additional","affiliation":[{"name":"The Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia"},{"name":"The Department of Neonatal Medicine, The Women\u2019s and Children\u2019s Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Voss","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Starship Children\u2019s Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y. C.","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Victorian Infectious Diseases Service, The Royal Melbourne Hospital, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha C.","family":"Bowen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Perth, Western Australia, Australia"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"McQuilten","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Webb","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Paterson","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Heriot","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Roberts","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Scarborough","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lye","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Walls","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Morpeth","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Boyles","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bonten","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein P.M","family":"Hensgens","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Daneman","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"Goodman","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cheng","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cosgrove","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Whiteway","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Van Hal","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Lee","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J","family":"Lewis","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Robinson","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Hardy","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Malham\u00e9","sequence":"additional","affiliation":[{"name":"for the Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"psc240001r1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1345\/aph.140023","article-title":"Therapeutic orphans\u2014everybody\u2019s business.","volume":"40","author":"Shirkey","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"19","key":"psc240001r2","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1001\/jama.2020.25007","article-title":"Incorporating adult evidence into pediatric research and practice: bayesian designs to expedite obtaining child-specific evidence.","volume":"325","author":"Murthy","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"psc240001r3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41390-020-1067-3","article-title":"Inclusion of children and pregnant women in COVID-19 intervention trials.","volume":"89","author":"Malhotra","year":"2021","journal-title":"Pediatr Res"},{"issue":"6","key":"psc240001r4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/eahr.500107","article-title":"Physician perspectives on including pregnant women in Covid-19 clinical trials: time for a paradigm change.","volume":"43","author":"Trahan","year":"2021","journal-title":"Ethics Hum Res"},{"issue":"3","key":"psc240001r5","doi-asserted-by":"publisher","first-page":"e1002520","DOI":"10.1371\/journal.pmed.1002520","article-title":"Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: a cohort study.","volume":"15","author":"Hwang","year":"2018","journal-title":"PLoS Med"},{"key":"psc240001r6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.conctc.2017.11.006","article-title":"Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: findings from the Clinical Trials Transformation Initiative.","volume":"9","author":"Greenberg","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"issue":"4","key":"psc240001r7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0896","article-title":"Trends in off-label drug use in ambulatory settings: 2006-2015.","volume":"144","author":"Hoon","year":"2019","journal-title":"Pediatrics"},{"issue":"11","key":"psc240001r9","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus Network adaptive platform trial protocol: new tools for an old foe.","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"psc240001r10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/ijerph18020530","article-title":"The bayesian design of adaptive clinical trials.","volume":"18","author":"Giovagnoli","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"psc240001r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11616","article-title":"Comparison of bayesian vs frequentist adaptive trial design in the Stroke Hyperglycemia Insulin Network Effort Trial.","volume":"5","author":"Broglio","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"psc240001r12","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.jclinepi.2013.02.015","article-title":"Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.","volume":"66","author":"Connor","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"psc240001r13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12874-022-01603-y","article-title":"Improving clinical trials using bayesian adaptive designs: a breast cancer example.","volume":"22","author":"Hong","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"psc240001r14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/pst.1589","article-title":"Use of historical control data for assessing treatment effects in clinical trials.","volume":"13","author":"Viele","year":"2014","journal-title":"Pharm Stat"},{"issue":"6","key":"psc240001r15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/10543406.2020.1821704","article-title":"A bayesian adaptive two-stage design for pediatric clinical trials.","volume":"30","author":"Psioda","year":"2020","journal-title":"J Biopharm Stat"},{"issue":"10","key":"psc240001r16","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","article-title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.","volume":"79","author":"Brunner","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"psc240001r17","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1097\/CCM.0b013e3181a59357","article-title":"No child left behind: enrolling children and adults simultaneously in critical care randomized trials.","volume":"37","author":"Halpern","year":"2009","journal-title":"Crit Care Med"},{"issue":"3","key":"psc240001r18","doi-asserted-by":"publisher","first-page":"e059872","DOI":"10.1136\/bmjopen-2021-059872","article-title":"Selumetinib in combination with dexamethasone for the treatment of relapsed\/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I\/II trial.","volume":"12","author":"Menne","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"psc240001r19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/00003246-199704000-00004","article-title":"A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation.","volume":"25","author":"Kollef","year":"1997","journal-title":"Crit Care Med"},{"issue":"20","key":"psc240001r20","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1001\/jama.288.20.2561","article-title":"Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial.","volume":"288","author":"Randolph","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"psc240001r21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7326\/0003-4819-151-3-200908040-00126","article-title":"Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.","volume":"151","author":"Luce","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10369","key":"psc240001r22","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"psc240001r23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapediatrics.2016.1477","article-title":"Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand children.","volume":"170","author":"McMullan","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"3","key":"psc240001r24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1179\/1465328111Y.0000000044","article-title":"Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance.","volume":"32","author":"Groome","year":"2012","journal-title":"Paediatr Int Child Health"},{"issue":"5","key":"psc240001r25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","article-title":"The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study.","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"psc240001r26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3201\/eid1104.040772","article-title":"Staphylococcus aureus bacteremia, Australia.","volume":"11","author":"Collignon","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"psc240001r27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia.","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"psc240001r28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0134","article-title":"Clinical management of Staphylococcus aureus bacteremia in neonates, children, and adolescents.","volume":"146","author":"McMullan","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"psc240001r29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/cid\/ciab510","article-title":"Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome.","volume":"74","author":"Campbell","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"psc240001r30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1651-2227.1989.tb10887.x","article-title":"Staphylococcus aureus bacteraemia in children below the age of one year. a review of 407 cases.","volume":"78","author":"Espersen","year":"1989","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"psc240001r31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1753495X231163351","article-title":"Walking the walk to include pregnant participants in non-obstetric clinical trials: insights from the SNAP Trial.","volume":"16","author":"Malham\u00e9","year":"2023","journal-title":"Obstet Med"},{"issue":"1","key":"psc240001r32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1186\/s13063-022-07023-z","article-title":"Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial.","volume":"23","author":"Symons","year":"2022","journal-title":"Trials"},{"issue":"1","key":"psc240001r33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1186\/s13063-023-07718-x","article-title":"A blueprint for a multi-disease, multi-domain bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial.","volume":"24","author":"Mahar","year":"2023","journal-title":"Trials"},{"issue":"6","key":"psc240001r34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/pst.2039","article-title":"A bayesian approach in design and analysis of pediatric cancer clinical trials.","volume":"19","author":"Ye","year":"2020","journal-title":"Pharm Stat"},{"key":"psc240001r8","unstructured":"US Food and Drug Administration. Enhancing the diversity of clinical trial populations\u2014eligibility criteria, enrollment practices, and trial designs guidance for industry. Published November 2020. Accessed July 16, 2024. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/enhancing-diversity-clinical-trial-populations-eligibility-criteria-enrollment-practices-and-trial"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2822488\/jamapediatrics_campbell_2024_sc_240001_1728048777.71276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T15:01:32Z","timestamp":1728313292000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2822488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2024.2697","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}